Immunovant Legal Officer Executes Mandatory Stock Sales Amid Strong Analyst Outlook
Christopher Van Tuyl, Chief Legal Officer at Immunovant, Inc. (NASDAQ:IMVT), executed a series of mandatory stock sales on July 8, 2026, to satisfy tax withholding requirements associated with restricted stock unit settlements. The transactions, totaling $47,702, involved the liquidation of 1,206 shares at prices closely tracking the stock's curren…